Track HilleVax Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

HilleVax Inc. Common Stock HLVX · Stock Open HilleVax Inc. Common Stock in new tab

1.68 USD
Add to portfolio
EPS
-3.38
P/B
0.37
ROE
-73.77
Beta
0.79
Target Price
2.33 USD
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
EPS-3.38
Book Value4.29
Price to Book0.37
Debt/Equity24.92
% Insiders17.139%
Estimates
Forward P/E-0.96
Forward EPS-1.67
Target Mean Price2.33

DCF Valuation

Tweak assumptions to recompute fair value for HilleVax Inc. Common Stock (HLVX)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

HilleVax Inc. Common Stock Logo HilleVax Inc. Common Stock Analysis (HLVX)

United States Health Care Official Website Stock

Is HilleVax Inc. Common Stock a good investment? HilleVax Inc. Common Stock (HLVX) is currently trading at 1.68 USD. Market analysts have a consensus price target of 2.33 USD. This suggests a potential upside from current levels.

Investor FAQ

Does HilleVax Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is HilleVax Inc. Common Stock?

HilleVax Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.

Exchange Ticker
NMS (United States) HLVX
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion